These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11774100)
1. Pulmonary renal syndrome: a 4-year, single-center experience. Gallagher H; Kwan JT; Jayne DR Am J Kidney Dis; 2002 Jan; 39(1):42-7. PubMed ID: 11774100 [TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane. Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059 [TBL] [Abstract][Full Text] [Related]
3. The role ANCA and anti-GBM antibodies in pulmonary-renal syndrome due to Wegener's granulomatosis. Zycinska K; Wardyn KA; Zielonka TM; Otto M J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):839-46. PubMed ID: 18204198 [TBL] [Abstract][Full Text] [Related]
4. Incidence and features of dual anti-GBM-positive and ANCA-positive patients. DE Zoysa J; Taylor D; Thein H; Yehia M Nephrology (Carlton); 2011 Nov; 16(8):725-9. PubMed ID: 21649794 [TBL] [Abstract][Full Text] [Related]
5. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672 [TBL] [Abstract][Full Text] [Related]
6. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043 [TBL] [Abstract][Full Text] [Related]
7. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients. Cui Z; Zhao J; Jia XY; Zhu SN; Zhao MH Am J Kidney Dis; 2011 Apr; 57(4):575-82. PubMed ID: 21168945 [TBL] [Abstract][Full Text] [Related]
8. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. de Lind van Wijngaarden RA; Hauer HA; Wolterbeek R; Jayne DR; Gaskin G; Rasmussen N; Noël LH; Ferrario F; Waldherr R; Hagen EC; Bruijn JA; Bajema IM J Am Soc Nephrol; 2006 Aug; 17(8):2264-74. PubMed ID: 16825335 [TBL] [Abstract][Full Text] [Related]
9. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases. Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400 [TBL] [Abstract][Full Text] [Related]
10. Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy. Cohen BA; Clark WF Am J Kidney Dis; 2000 Nov; 36(5):914-24. PubMed ID: 11054347 [TBL] [Abstract][Full Text] [Related]
11. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients. Harper L; Savage CO Rheumatology (Oxford); 2005 Apr; 44(4):495-501. PubMed ID: 15613403 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis. Kokolina E; Alexopoulos E; Dimitriadis C; Vainas A; Giamalis P; Papagianni A; Ekonomidou D; Memmos D Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000 [TBL] [Abstract][Full Text] [Related]
14. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Guillevin L; Durand-Gasselin B; Cevallos R; Gayraud M; Lhote F; Callard P; Amouroux J; Casassus P; Jarrousse B Arthritis Rheum; 1999 Mar; 42(3):421-30. PubMed ID: 10088763 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement. Rihova Z; Jancova E; Merta M; Rysava R; Reiterova J; Zabka J; Tesar V Kidney Blood Press Res; 2005; 28(3):144-52. PubMed ID: 15908752 [TBL] [Abstract][Full Text] [Related]
16. Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease = report of six cases. Bonsib SM; Goeken JA; Kemp JD; Chandran P; Shadur C; Wilson L Mod Pathol; 1993 Sep; 6(5):526-30. PubMed ID: 8248108 [TBL] [Abstract][Full Text] [Related]
17. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976 [TBL] [Abstract][Full Text] [Related]
18. Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center. Li ZY; Gou SJ; Chen M; Zhao MH Semin Arthritis Rheum; 2013 Apr; 42(5):515-21. PubMed ID: 23332902 [TBL] [Abstract][Full Text] [Related]